Written by:
Dr. Sophie Reynolds
Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Alecensa 150 mg Capsule
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
| Image | Product | Manufacturer / Marketed By | Price |
|---|---|---|---|
![]() | LuciAle 150 mg Capsule | Lucius Pharma | Ask for Price |
![]() | Alecnib 150 mg Capsule | Everest Pharma | Ask for Price |
Description
Alecensa Capsules are manufactured by ROCHE PRODUCTS INDIA PVT LTD in Switzerland and contain 150 mg of Alectinib per capsule. Each Bottle includes 240 Capsule in 1 Bottle, making Alecensa Capsules an effective option for Lung Cancer. Prescription Required from your healthcare provider to purchase Alectinib medicine. Indogenmed deals in all type of generic Alectinib medicine.
Benefits
-
Targets ALK-driven cancer cells directly
-
Helps slow tumor growth and metastasis
-
Proven improvement in progression-free survival
-
Effective for brain metastases due to strong CNS penetration
-
Convenient oral dosing for long-term therapy
Indications and Usage
Alecensa 150 mg Capsule is indicated for:
-
ALK-positive metastatic non-small cell lung cancer (NSCLC)
-
First-line treatment or after progression on another ALK inhibitor
ALK-positive status must be confirmed through approved diagnostic testing.
How it Works
Alectinib blocks abnormal ALK signaling, a genetic mutation that drives cancer cell growth in certain lung cancers. By inhibiting this pathway, it slows tumor development, spread, and survival.
Dosage & Administration
-
Usual dose: 600 mg per day (150 mg × 4 capsules), divided into two doses
-
Take with food, at consistent times daily
-
Swallow capsules whole—do not crush or open
-
Continue until disease progression or unacceptable toxicity
-
Regular liver, kidney, heart rate, and blood tests are required
Use only under oncologist supervision.
Side Effects
Common side effects:
-
Fatigue or weakness
-
Constipation
-
Swelling in hands or feet
-
Muscle pain
-
Rash
-
Low red blood cell count
Serious side effects (seek urgent care):
-
Liver toxicity
-
Lung inflammation (pneumonitis)
-
Severe muscle damage (high CPK levels)
-
Slow or irregular heartbeat
-
Kidney dysfunction
Warning and Precaution
-
Not recommended during pregnancy or breastfeeding
-
Monitor for liver, lung, muscle, and heart-related side effects
-
Avoid driving if experiencing dizziness or vision changes
-
Inform doctor about all medications to prevent interactions
-
Report breathing difficulty, severe fatigue, jaundice, or muscle pain immediately
Related Products
Related Posts:
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.n n Brain tumors, especially high-grade
READ MORE »Only logged in customers who have purchased this product may leave a review.

Reviews
Clear filtersThere are no reviews yet.